Recent comments

  • Reply to: We Confuse, You Decide   18 years 1 week ago

    Soooo . . . Kansas Health Dept., do you also inform parents that the innoculations that you are giving their babies contains mercury and may cause autism, or that the aspirin you are giving them may cause internal bleeding, or that the high blood pressure meds you are giving can cause strokes, heart attacks and diabetes. Do you also inform your prospective abortion patient that by not having any children that they can expect to live 10 years longer. Did you also tell your prospective patient that the increase in breast cancer is not actually from the abortion, that it is possibly from never having breast fed. So while you are researching that, do some research on the sad facts of children brought up in homes where they are not wanted. Shame on you for wishing that on a child.

  • Reply to: Troops, Hoops and Antichoice Brutes   18 years 1 week ago

    so typical of men, I wonder how many of these men actually have custody of their children, have had unprotected sex with their baseball groupies and never kept in contact about any possible children, how many of these men need to be hauled into court to pay any financial support. If any of these men actually contributed to the non-stop 24 hour a day, 7 days a week child rearing, I may be interested in what they have to say. Until the day happens that men are completely and entirely responsible and self sacrificing like the women, they can keep their obviously uninformed opinions to themselves.

  • Reply to: Some Like It Hot   18 years 1 week ago

    How do they figure into this?

  • Reply to: Some Like It Hot   18 years 1 week ago

    99.9% of climate change 'skeptics' seem to have some connection to industry in one way or another. The remainders are just victims of their propaganda. That certainly goes for the CATO Institute which is heavily funded by energy companies - who have a vested interest - and not incidentally in the case of Exxon Mobil, an actual, foramilzed 'Global Warming Denial" plan.

    No rational individual who takes the time to seriously look into the global warming issue can look at the data -particularly the statistical charts - and not draw the inescapable conclusions.

    The saddest part for me is the realization that otherwise bright, articulate and well-educated people like Mr. Doudreaux seem quite willing - sometimes even eager - to prostitute themselves on behalf of their benefactors. They seem not to realize that their whoring for dollars will also condemn their own children and grand children along with the rest of us.

  • Reply to: Roche PR Spins Straw into Golden Cure   18 years 1 week ago

    Thanks to Bob Burton for calling my attention to earlier articles about Roche's full PR press for Herception. Of particular interest is an article in PR Week UK ("[http://www.prweek.com/uk/search/article/521600// Analysis: The drug buoyed by patient power]," October 13, 2005, sub req'd):

    Tonic Life Communications CEO Scott Clark, who was involved in global pre-launch work for Herceptin at his previous agency, concurs: 'This is one of those legacy campaigns, perhaps in the top three in the past decade, that has had genuine impact. If people are sceptical of the power of PR, Roche has a clear case study on how a good story can move markets and mindsets.' ...

    Roche uses Ketchum to handle UK PR for the drug. Sébastien Desprez, associate director at the agency, can now reflect on an 'onslaught' of interest. He describes Barbara Clark, with whom Roche says it has only dealt reactively (supplying her with product information, and so on), as 'amazing at orchestrating PR'.

    Separately, Fighting for Herceptin (FfH), established by a group of Staffordshire women, has also caught the media's attention. Porter Novelli has, it emerges, been advising FfH for the past month and has a four-strong team on the pro bono account. PN UK healthcare head Rebecca Hunt, who left a job at Roche earlier this year, says: 'I got to know FfH founder Dorothy Griffiths when I was at Roche, and we kept in touch. When Barbara Clark made the news I saw FfH was banging the drum too, and I asked Dorothy if she wanted any professional PR support.'

    Another article, by Anne Hall in BMJ, gives a journalist's view of the Herceptin PR push ("[http://bmj.bmjjournals.com/cgi/content/full/321/7261/644 Ads: Not Another Magic Bullet]," September 9, 2000):

    When a public relations company asked me to a press briefing in Milan to hear about this new drug [Herceptin], I hesitated. ...

    Dr Paul Ellis, a consultant oncologist at Guy's Hospital, London, also thought that the story should be told. "This is the first targeted treatment for breast cancer," he said, "which has real clinical benefits for the patients we see every day in the clinic. It represents a whole new era of cancer care, and for me that is truly exciting."

    Dr Ellis was paid an honorarium of $1000 by the makers or trastuzumab to go to Milan, but said "I was certainly not there as a hired hand for the drug company."

    The honorarium, he said, was "normal practice for any clinician attending such a meeting, and takes into account our time away from our families and the overnight stay."

Pages